ucsf logo

Nailyn Rasool, MD

Strabismus • Neuro-Ophthalmology
Neuro-Ophthalmology Parnassus
415-353-2020
ucsf logo

Nailyn Rasool, MD

Strabismus • Neuro-Ophthalmology
Neuro-Ophthalmology Parnassus
415-353-2020

On this page

About me

Dr. Nailyn Rasool specializes in diagnosing and managing complex neurologic diseases affecting vision. Her expertise in complex eye-brain interactions enables her to provide care for patients with a wide variety of conditions, including optic nerve disorders, neuromuscular disorders, strabismus (misaligned eyes), increased pressure in the brain (intracranial hypertension) and double vision. She may treat double vision with prism glasses, Botox injections or strabismus surgery.

Rasool earned her medical degree at the University of British Columbia. She completed a residency in neurology at Dalhousie University in Nova Scotia. During her residency, she obtained certification in electromyography (a procedure that records the electrical activity of muscles), developing expertise in diagnosing neuromuscular conditions. She then completed a fellowship in neuro-ophthalmology at Massachusetts Eye and Ear, a teaching hospital of Harvard Medical School, and a residency in ophthalmology at Columbia University.

Rasool is an active member of the American Academy of Ophthalmology, American Academy of Neurology and North American Neuro-Ophthalmology Society. She is a fellow of the Royal College of Physicians and Surgeons of Canada.

Education & training

Board certification

  • Ophthalmology, American Board of Ophthalmology
  • Neurology, The Royal College of Physicians and Surgeons

Fellowship

  • Neuro-Ophthalmology, Massachusetts Eye and Ear Infirmary- Chief & Chair

Residency

  • Ophthalmology, Columbia University Medical Center GME
  • Neurology, Dalhousie University

Degree

  • MD, University of British Columbia

My expertise

  • Specialties
  • Conditions
    • Optic Neuropathy
    • Myasthenia Gravis
    • Facial Spasm
    • Ocular Motility Disorders
    • Strabismus
    • Optic Neuritis
    • Neuromyelitis Optica (NMO)

Locations

    Reviews

    Average rating

    4.9
    4.9 out of 5 Stars
    146 ratings
    About provider reviews

    Showing 1-6 of 33 reviews

    Sort by
    • 5 out of 5 Stars
      January 20, 2026

      Dr. Rasool and Dr. Lin are highly appreciated for their professionalism, expertise, and friendly demeanor.

    • 5 out of 5 Stars
      December 9, 2025

      Dr. Nailyn Rasool is an excellent doctor and communicator. My wife who has stage 4 dementia was always comfortable with Dr. Rasool's examinations, treatments, and follow up visits.

    • 5 out of 5 Stars
      December 3, 2025

      Excellent

    • 5 out of 5 Stars
      October 14, 2025

      I was seen by Dr. Lin for the first time; Dr. Lin was extremely thorough, listened very carefully, informed me of everything during the exam and made sure I was given the best care. Dr. Rasool was wonderful as always. Dr. Rasool always takes time to listen, always asks questions that make her patients feel they are seen, and always ensures the best possible advice and options are explained. This practice is absolutely invaluable. I would recommend the practice to anyone who needs this kind of care without reservation. I hope UCSF continues to support and recognize this practice.

    • 5 out of 5 Stars
      October 11, 2025

      Doctor Rasool always goes the Xtra mile Gives exceptional care. She is awesome.

    • 5 out of 5 Stars
      October 6, 2025

      Both doctors were very friendly. They were methodical with their tests, questions, answers, etc. It was a very good and informative visit.

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.